Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
21.4M
-
Shares change
-
+471K
-
Total reported value, excl. options
-
$867M
-
Value change
-
+$19.3M
-
Put/Call ratio
-
1.41
-
Number of buys
-
59
-
Number of sells
-
-67
-
Price
-
$40.58
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2019
162 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2019.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.4M shares
of 835M outstanding shares and own 2.56% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (4.15M shares), BlackRock Inc. (1.78M shares), RENAISSANCE TECHNOLOGIES LLC (1.71M shares), VANGUARD GROUP INC (1.12M shares), DIMENSIONAL FUND ADVISORS LP (936K shares), GOLDMAN SACHS GROUP INC (893K shares), Aperio Group, LLC (744K shares), STATE STREET CORP (736K shares), WELLINGTON MANAGEMENT GROUP LLP (669K shares), and Parametric Portfolio Associates LLC (628K shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.